Key points are not available for this paper at this time.
Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase involved in the regulation of many cellular processes. A confirmed tumor suppressor protein, PP2A is genetically altered or functionally inactivated in many cancers highlighting a need for its therapeutic reactivation. In this review we discuss recent literature on PP2A: the elucidation of its structure and the functions of its subunits, and the identification of molecular lesions and post-translational modifications leading to its dysregulation in cancer. A final section will discuss the proteins and small molecules that modulate PP2A and how these might be used to target dysregulated forms of PP2A to treat cancers and other diseases.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jaya Sangodkar
Caroline Farrington
Kimberly McClinch
FEBS Journal
Case Western Reserve University
Icahn School of Medicine at Mount Sinai
Building similarity graph...
Analyzing shared references across papers
Loading...
Sangodkar et al. (Wed,) studied this question.
synapsesocial.com/papers/6a0932c9c64d0aaf94b62775 — DOI: https://doi.org/10.1111/febs.13573
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: